These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1740601)

  • 1. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies.
    Powers DC; Murphy BR; Fries LF; Adler WH; Clements ML
    J Am Geriatr Soc; 1992 Feb; 40(2):163-7. PubMed ID: 1740601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.
    Powers DC; Sears SD; Murphy BR; Thumar B; Clements ML
    J Clin Microbiol; 1989 Dec; 27(12):2666-71. PubMed ID: 2592535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
    Clements ML; Murphy BR
    J Clin Microbiol; 1986 Jan; 23(1):66-72. PubMed ID: 3700610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates.
    Boonnak K; Paskel M; Matsuoka Y; Vogel L; Subbarao K
    Vaccine; 2012 Aug; 30(38):5603-10. PubMed ID: 22789506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine.
    Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
    J Med Virol; 1985 Dec; 17(4):325-35. PubMed ID: 4078559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.
    Powers DC; Fries LF; Murphy BR; Thumar B; Clements ML
    J Clin Microbiol; 1991 Mar; 29(3):498-505. PubMed ID: 2037667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly.
    Stepanova L; Naykhin A; Kolmskog C; Jonson G; Barantceva I; Bichurina M; Kubar O; Linde A
    J Clin Virol; 2002 Apr; 24(3):193-201. PubMed ID: 11856620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases.
    Gorse GJ; Belshe RB; Munn NJ
    J Clin Microbiol; 1986 Sep; 24(3):336-42. PubMed ID: 3531226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB; Gruber WC; Mendelman PM; Mehta HB; Mahmood K; Reisinger K; Treanor J; Zangwill K; Hayden FG; Bernstein DI; Kotloff K; King J; Piedra PA; Block SL; Yan L; Wolff M
    J Infect Dis; 2000 Mar; 181(3):1133-7. PubMed ID: 10720541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
    Treanor JJ; Roth FK; Betts RF
    J Clin Microbiol; 1990 Mar; 28(3):596-9. PubMed ID: 2182673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.
    Muszkat M; Greenbaum E; Ben-Yehuda A; Oster M; Yeu'l E; Heimann S; Levy R; Friedman G; Zakay-Rones Z
    Vaccine; 2003 Mar; 21(11-12):1180-6. PubMed ID: 12559796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
    Rudenko L; Desheva J; Korovkin S; Mironov A; Rekstin A; Grigorieva E; Donina S; Gambaryan A; Katlinsky A
    Influenza Other Respir Viruses; 2008 Nov; 2(6):203-9. PubMed ID: 19453396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of seronegative and seropositive adult volunteers to live attenuated cold-adapted reassortant influenza A virus vaccine.
    Clements ML; Tierney EL; Murphy BR
    J Clin Microbiol; 1985 Jun; 21(6):997-9. PubMed ID: 4008629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.
    Hughes HR; Vincent AL; Brockmeier SL; Gauger PC; Pena L; Santos J; Braucher DR; Perez DR; Loving CL
    Clin Vaccine Immunol; 2015 Oct; 22(10):1109-20. PubMed ID: 26291090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immune responses following administration of H1N1 live attenuated influenza vaccine in Thais.
    Phonrat B; Pitisuttithum P; Chamnanchanunt S; Puthavathana P; Ngaosuwankul N; Louisirirotchanakul S; Dhitavat J; Thirapakpoomanunt S; Chokevivat V; Wibulpolprasert S
    Vaccine; 2013 Mar; 31(11):1503-9. PubMed ID: 23318149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults.
    Ainai A; Tamura S; Suzuki T; van Riet E; Ito R; Odagiri T; Tashiro M; Kurata T; Hasegawa H
    Hum Vaccin Immunother; 2013 Sep; 9(9):1962-70. PubMed ID: 23896606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.
    Sears SD; Clements ML; Betts RF; Maassab HF; Murphy BR; Snyder MH
    J Infect Dis; 1988 Dec; 158(6):1209-19. PubMed ID: 3198936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
    Talaat KR; Karron RA; Callahan KA; Luke CJ; DiLorenzo SC; Chen GL; Lamirande EW; Jin H; Coelingh KL; Murphy BR; Kemble G; Subbarao K
    Vaccine; 2009 Jun; 27(28):3744-53. PubMed ID: 19464558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children.
    Edwards KM; Snyder P; Thompson JM; Johnson PR; Wright PF
    Vaccine; 1986 Mar; 4(1):50-4. PubMed ID: 3962451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class-specific antibody responses in school children vaccinated with an A/Brazil/11/78 (H1N1)-like recombinant influenza virus prepared from the A/Leningrad/134/57 paediatric cold-adapted donor strain.
    Slepushkin AN; Patriarca PA; Obrosova-Serova NP; Harmon MW; Kupryashina LN; Cheshik SG; Vartanyan RB; Alexandrova GI; Polezhaev FI; Lonskaya NI
    Vaccine; 1988 Feb; 6(1):25-8. PubMed ID: 3354254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.